TY - JOUR
T1 - Sleep medicine pharmacotherapeutics overview
T2 - Today, tomorrow, and the future (Part 1: Insomnia and circadian rhythm disorders)
AU - Gulyani, Seema
AU - Salas, Rachel E.
AU - Gamaldo, Charlene E.
PY - 2012/12
Y1 - 2012/12
N2 - Over the past 10 years, significant strides have been made in the understanding, development, and availability of sleep disorder therapeutics. In this review series, we discuss the current evidence surrounding the mechanisms of actions, indications, efficacy, and adverse side effects associated with the available armamentarium of sleep over-the-counter and pharmacotherapeutics. This article is the first of a two-part series that covers the therapeutics for insomnia and circadian rhythm disorders.
AB - Over the past 10 years, significant strides have been made in the understanding, development, and availability of sleep disorder therapeutics. In this review series, we discuss the current evidence surrounding the mechanisms of actions, indications, efficacy, and adverse side effects associated with the available armamentarium of sleep over-the-counter and pharmacotherapeutics. This article is the first of a two-part series that covers the therapeutics for insomnia and circadian rhythm disorders.
UR - http://www.scopus.com/inward/record.url?scp=84870602082&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84870602082&partnerID=8YFLogxK
U2 - 10.1378/chest.12-0465
DO - 10.1378/chest.12-0465
M3 - Review article
C2 - 23208340
AN - SCOPUS:84870602082
VL - 142
SP - 1659
EP - 1668
JO - Diseases of the chest
JF - Diseases of the chest
SN - 0012-3692
IS - 6
ER -